Pulse Reviews and Analysis
Should I open or buy an iCRYO cryotherapy franchise in 2027?
Curated by Kory White · Fractional CRO, CRO Syndicate
Direct Answer
Yes if you want into the recovery-wellness boom at a lower capital point than Restore — iCRYO is a cryotherapy-led recovery franchise with a membership model, but it shares the same compliance considerations for IV and clinical services. iCRYO, founded in 2015 in Texas, offers whole-body cryotherapy, IV drip therapy, infrared sauna, red-light therapy, compression, and body-sculpting under a membership + à la carte model.
The 2026 FDD lists a franchise fee around $40,000, total Item 7 investment of roughly $400,000 to $900,000, a royalty near 7%, and a marketing fee. Mature centers gross $500,000-$1,200,000, and owners clear $70,000-$220,000 when membership and IV services scale.
ICRYO's pitch is a lower-cost, cryo-anchored entry into the same category Restore leads — with the same need for clinical compliance on IV and medical services.
The Real Numbers
An iCRYO center leases 1,800-3,500 sq ft and installs cryo chambers, IV suites, infrared sauna, red-light, and compression equipment. The model blends recurring memberships, packages, and à la carte visits, with IV therapy a higher-ticket, compliance-bound revenue stream.
| Line Item | Low | High | Notes |
|---|---|---|---|
| Franchise fee | $40,000 | $40,000 | Per 2026 FDD |
| Leasehold / buildout | $120,000 | $350,000 | Retail fit-out, suites |
| Equipment | $140,000 | $340,000 | Cryo, IV, sauna, red-light |
| Technology & software | $12,000 | $40,000 | CRM, EMR, billing |
| Initial marketing | $25,000 | $70,000 | Pre-sale + grand opening |
| Insurance & compliance | $12,000 | $45,000 | Medical + GL |
| Training & travel | $6,000 | $20,000 | Clinical + ops training |
| Working capital | $60,000 | $150,000 | First 3-6 months |
| Total Item 7 | ~$400,000 | ~$900,000 | Per 2026 FDD |
| Royalty | ~7% of gross | ||
| Marketing fee | ~2% of gross |
Revenue reality: mature centers gross $500K-$1.2M, with memberships as the recurring base and IV/services as higher-ticket revenue. With labor (25%-32%), rent (12%-16%), royalty, and compliance costs, owners clear $70K-$220K. Breakeven typically takes 18-36 months.
The lower capital vs Restore reflects a smaller footprint and a cryo-anchored (vs hyperbaric-heavy) modality mix.
Who Wins With This Business
- Capital required: $400K-$900K, with $150,000-$300,000 liquid plus financing.
- Time commitment: 40-55 hours per week during ramp; semi-absentee possible with a strong manager.
- Skills: wellness-retail operations, membership sales, and compliance management.
- Geographic fit: affluent, health-conscious metros with recovery-wellness demand.
- Lifestyle fit: full-time during ramp, manageable once staffed.
The winners are operations-disciplined operators who want the recovery category at lower capital than Restore.
Who Loses With This Business
- Operators who underestimate IV/clinical compliance.
- À la carte-dependent centers without recurring memberships.
- Wrong-market centers in lower-income areas.
- Under-capitalized owners facing the $400K+ build.
- Owners who can't staff licensed clinical roles for IV therapy.
2027 Market Conditions
- Demand: recovery, longevity, and biohacking wellness is strong and growing into 2027.
- Competition: Restore Hyper Wellness, Perspire, The DRIPBaR, and independents; iCRYO's edge is lower-cost, cryo-anchored entry.
- Regulation: IV and clinical services face state medical-board and scope-of-practice rules — a compliance burden and moat.
- Membership economics: recurring revenue supports stability.
- Differentiation: body-sculpting and add-on modalities broaden revenue per member.
The 90-Day Decision Tree
- Day 1-20: Read the 2026 FDD and compliance requirements for IV/clinical services.
- Day 21-40: Interview 8+ owners; ask about membership vs IV revenue, compliance cost, and net profit, and compare directly to Restore.
- Day 41-60: Validate an affluent, health-conscious market.
- Day 61-90: Secure a site and arrange a medical director and clinical staffing.
- Day 91-120: Build out and pre-sell founding memberships.
- Open running both memberships and compliant IV/clinical services.
- Ongoing: scale recurring memberships and higher-ticket IV/service revenue.
Alternative Plays
- Restore Hyper Wellness — category leader with broader modalities at higher capital.
- Perspire Sauna Studio — simpler infrared-sauna membership, low compliance.
- The DRIPBaR — IV-focused wellness franchise.
- HOTWORX — infrared-fitness membership, low labor.
- Independent recovery lounge — full equity, no royalty, but no brand or systems.
- Med-spa franchises — adjacent higher-clinical models.
FAQ
How is iCRYO different from Restore Hyper Wellness?
iCRYO is a lower-capital, cryotherapy-anchored entry ($400K-$900K) into the same recovery-wellness category Restore leads ($600K-$1.5M). Restore offers a broader modality mix (including hyperbaric) and larger brand scale; iCRYO offers a smaller footprint and lower investment. Both require clinical compliance for IV services.
How much does an iCRYO owner make?
Owners clear $70,000-$220,000 at well-run centers, with memberships providing the recurring base and IV/services driving higher-ticket revenue. À la carte-only centers underperform. Market affluence and execution drive the range.
What is the compliance burden?
Real for IV and clinical services, which require a medical director, licensed staff, and adherence to state medical-board and scope-of-practice rules. This is an operating cost but also a moat against casual competitors.
What is the biggest risk?
Compliance missteps, wrong market, and under-capitalization. Centers in lower-income areas or those that mishandle IV compliance struggle. Affluent markets, disciplined compliance, and adequate capital are essential — and you should compare iCRYO and Restore franchisee satisfaction directly.
Is the recovery-wellness category durable?
Yes — it's strong and growing into 2027, driven by longevity and recovery trends among affluent consumers. The space is competitive, so brand, membership economics, and modality mix matter, but underlying demand is robust.
Bottom Line
Open an iCRYO franchise if you want into the recovery-wellness boom at a lower capital point than Restore ($400K-$900K) and will manage IV/clinical compliance in an affluent market. Its cryo-anchored membership model offers recurring revenue with high-ticket IV upside. Skip it if you're under-capitalized, in a lower-income market, or unwilling to manage medical compliance — and always compare it head-to-head with Restore and lower-compliance options like Perspire and HOTWORX before deciding.
Sources
- iCRYO Franchise Disclosure Document (2026 filing) — Items 5, 6, 7, 19, 20
- iCRYO official franchise site — investment range and modalities
- Entrepreneur Franchise listings — iCRYO and recovery-wellness category
- Franchise Business Review — wellness-franchise satisfaction data
- IBISWorld — Health & Wellness / Recovery Services in the US, 2026 industry report
- Global Wellness Institute — wellness-economy report 2025-2026
- Statista — US wellness and recovery-services market, 2025-2026
- State medical-board IV-therapy and scope-of-practice guidance, 2025-2026
- International Franchise Association (IFA) — 2027 Franchise Economic Outlook
- Grand View Research — Cryotherapy / IV Therapy market 2026